Marketing-authorisation holder · United States
Biomedcl Res Fdn
1 medicine in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMMONIA N 1313 15mCi-150mCi/4ML (3.75-37.5mCi/ML) | 13 18.8mCi-188mCi/5ML (3.75-37.5mCi/ML) | 13 22.5mCi-225mCi/6ML (3.75-37.5mCi/ML) | 13 3.75-260mCi/ML | 13 3.75mCi-260mCi/ML | 13 30mCi-300mCi (3.75-37.5mCi/ML) | 13 30mCi-300mCi/8ML (3.75-37.5mCi/ML) | 13 37.5mCi-800mCi/10ML (3.75-80mCi/ML) | 13 48.75mCi-487.5mCi/13ML (3.75-37.5mCi/ML) · Injectable | Ammonia n-13 | United States | Marketed | 2007 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.